# Icagen, Inc.: Form D filings

Icagen, Inc., a pharmaceuticals company in Durham, NC, filed 11 Form D notices with the SEC between 2011 and 2018. The latest, on September 12, 2018, reports $7.3 million sold of a $7.3 million offering to 1 investor.

Find out what Icagen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Icagen%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Icagen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ficagen-inc-1518520)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Icagen%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Icagen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ficagen-inc-1518520)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4222 EMPEROR BLVD., SUITE 350, RESEARCH TRIANGLE PARK, Durham, NC, 27703
- Phone: (919) 941-5206
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1518520

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 12, 2018 | New notice | $7,250,000 | $7,250,000 | $0 | 1 | Aug 31, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390018012433/0001213900-18-012433-index.htm) |
| Aug 15, 2018 | New notice | $1,500,000 | $500,000 | $1,000,000 | 4 | Aug 13, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390018011202/0001213900-18-011202-index.htm) |
| Apr 12, 2018 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 1 | Apr 4, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390018004354/0001213900-18-004354-index.htm) |
| May 25, 2017 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | May 15, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390017005834/0001213900-17-005834-index.htm) |
| Apr 28, 2017 | New notice | $1,500,000 | $1,500,000 | $0 | 3 | Apr 12, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390017004351/0001213900-17-004351-index.htm) |
| Jul 8, 2016 | New notice | $1,145,000 | $1,145,000 | $0 | 12 | Jun 27, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390016014819/0001213900-16-014819-index.htm) |
| Jan 15, 2015 | Amendment | $8,855,000 | $8,855,000 | $0 | 162 | Dec 10, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390015000331/0001213900-15-000331-index.htm) |
| Dec 16, 2014 | New notice | $7,875,000 | $49,000 | $7,826,000 | 2 | Dec 10, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390014008936/0001213900-14-008936-index.htm) |
| May 10, 2013 | Amendment | $5,000,000 | $3,135,000 | $1,865,000 | 61 | Apr 17, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390013002377/0001213900-13-002377-index.htm) |
| Apr 29, 2013 | New notice | $5,000,000 | $1,550,000 | $3,450,000 | 28 | Apr 17, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000121390013002086/0001213900-13-002086-index.htm) |
| May 19, 2011 | New notice | $2,000,000 | $1,097,950 | $902,050 | 0 | May 13, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1518520/000151852011000001/0001518520-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Vincent Palmieri | Director |  |
| Timothy Tyson | Director |  |
| Douglas Krafte | Executive Officer |  |
| Mark Korb | Executive Officer |  |
| Edward Roffman | Director |  |
| Richard Cunningham | Executive Officer |  |
| Clive Kabatznik | Director |  |
| Michael Taglich | Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Sep 10, 2018](https://specstream.ai/data/form-d/week/2018-09-10) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Icagen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).